Leqembi Safety Is Focus Of Three Postmarketing Requirements From US FDA

 
• By Sue Sutter
  
Arrows on road
When Leqembi converted to full approval, Eisai traded a required confirmatory trial for three mandatory safety studies. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approvals

More from Product Reviews